S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7229 −0.32%
CLOSED · 15:35 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead

ALKS

Alkermes plc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
46.10
−0.78 −1.66%
USD · Sep 6, 01:17 a.m. ET
MKT CAP $7.7BP/E 121.3DIV YIELD FCF YIELD 2.87%REV TTM $1.7B +10.8%NET INCOME $66.1M −81.0%NET DEBT $1B52W 26.52 – 55.22SEC XBRL · TTM TO Invalid Date

Who holds it

SEC 13F · LATEST QUARTER PER FUND
FundTypeRank in portfolioValueSharesAs of
Renaissance TechnologiesGuru#31$338.5M6.5M2026-06-30
PSP InvestmentsPension#157$35.5M677K2026-06-30

13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.

Stakes of 5% or more

SCHEDULE 13D / 13G · LATEST PER HOLDER · TWO YEARS
No 13D or 13G filing on ALKS in the last two years from the filings we read (13G only for companies we track; the sweep began Sep 2026).

A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.

Watch ALKS. Know when insiders buy.
One email the day a filing lands. Free.